Literature DB >> 1341445

Use of pleural fluid C-reactive protein in laboratory diagnosis of pleural effusions.

J L Castaño Vidriales1, C Amores Antequera.   

Abstract

OBJECTIVES: C-reactive protein (CRP) which is synthetized by hepatocytes is an acute phase protein and its serum level increases within 6-9 hours after infection or tissue damage. We investigated its usefulness as a marker of bacterial infection in patients with pleural effusion.
METHODS: We studied the usefulness of pleural fluid C-reactive protein measurement in a population of 72 patients with pleural effusion, by means of an immunoturbidimetric method (Hitachi 717, Boheringer Mannheim). A comparison of serum and pleural effusion C-reactive protein levels in different subgroups of patients with effusion was made.
RESULTS: According to preset diagnostic criteria, 19 patient effusions were classified as transudates and the mean (+/- 5 D) pleural fluid CRP [5.3 (+/- 7.8) mg per liter, p < 0.001] were significantly lower than those in the exudate effusions group. Among the 53 patients with exudate effusion, eight were caused by neoplastic disease and the pleural fluid CRP mean (29.3 +/- 16.1 mg per liter, p < 0.001) were significantly lower than those in exudates from parapneumonic effusions (122.7 +/- 48.0 mg per liter, p < 0.001) and than those in the exudates from patients with effusion associated with tuberculosis (67.8 +/- 32.1 mg per liter, p < 0.001). Moreover, all but two transudates had a C-reactive protein lower than 10 mg/L, whereas only two exudates with tuberculosis origin had a C-reactive protein value lower than 10 mg/L, instead all pleural-fluid C-reactive protein from exudates with pneumonia were greater than 10 mg/L. We had found a correlation between the pleural and serum C-reactive protein (r = 0.6884, p < 0.0001). And transudates tended to have lower ratios of pleural to serum CRP (0.26) than exudates (0.55), and malignant effusions had lower ratios (0.37) than pneumonic and tuberculous effusions (0.52, 0.58).
CONCLUSIONS: Pleural fluid CRP > 10 mg per liter had good sensitivity (82%), specificity (87.5%) and predictive value of positivity (95.5%) in the diagnosis of exudate effusions and higher CRP-levels may prove to be a practical, accurate and rapid method for differentiating pneumonic effusions and effusions associated with tuberculosis from others. It can be considered that quantitative immunoturbidimetric assay of pleural-fluid C-reactive protein will be a useful diagnostic tool to differentiate pleural effusions with bacterial origin from others.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1341445

Source DB:  PubMed          Journal:  Eur J Med        ISSN: 1165-0478


  11 in total

1.  Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema.

Authors:  S C Chen; W Chen; W H Hsu; Y H Yu; C M Shih
Journal:  Lung       Date:  2006 May-Jun       Impact factor: 2.584

2.  Diagnostic accuracy of tumour markers in serous effusions: a validation study.

Authors:  Jaume Trapé; Rafael Molina; Francesc Sant; Jesús Montesinos; Anna Arnau; Josefina Franquesa; Rosana Blavia; Esperanza Martín; Emili Marquilles; Damià Perich; Concepción Pérez; Josep Maria Roca; Montserrat Doménech; Joan López; Josep Miquel Badal
Journal:  Tumour Biol       Date:  2012-06-08

3.  The Role of Pleural Fluid C-Reactive Protein in the Diagnosis of Exudative Pleural Effusions.

Authors:  Sanket Makwana; Prashant Gohil; Yash Gabhawala
Journal:  Cureus       Date:  2022-07-19

4.  Pleural fluid analysis: standstill or a work in progress?

Authors:  T Hassan; M Al-Alawi; S H Chotirmall; N G McElvaney
Journal:  Pulm Med       Date:  2012-02-01

5.  The acute-phase proteins serum amyloid A and C reactive protein in transudates and exudates.

Authors:  Alessandra M Okino; Cristiani Bürger; Jefferson R Cardoso; Edson L Lavado; Paulo A Lotufo; Ana Campa
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

6.  Evaluation of two strategies for the interpretation of tumour markers in pleural effusions.

Authors:  Jaume Trapé; Francesc Sant; Josefina Franquesa; Jesús Montesinos; Anna Arnau; Maria Sala; Oscar Bernadich; Esperanza Martín; Damià Perich; Concha Pérez; Joan Lopez; Sandra Ros; Enrique Esteve; Rafael Pérez; Jordi Aligué; Gabriel Gurt; Silvia Catot; Montserrat Domenech; Joan Bosch; Josep Miquel Badal; Mariona Bonet; Rafael Molina; Josep Ordeig
Journal:  Respir Res       Date:  2017-05-25

Review 7.  A systematic review of the association between circulating concentrations of C reactive protein and cancer.

Authors:  Katriina Heikkilä; Shah Ebrahim; Debbie A Lawlor
Journal:  J Epidemiol Community Health       Date:  2007-09       Impact factor: 3.710

8.  Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer patients with malignant pleural effusions.

Authors:  Do-Sim Park; Dong Kim; Ki-Eun Hwang; Yu-Ri Hwang; Chul Park; Chang-Hwan Seol; Kyung-Hwa Cho; Byoung-Ryun Kim; Seong-Hoon Park; Eun-Taik Jeong; Hak-Ryul Kim
Journal:  Yonsei Med J       Date:  2013-03-01       Impact factor: 2.759

9.  The Diagnostic Value of the Pleural Fluid C-Reactive Protein in Parapneumonic Effusions.

Authors:  Shimon Izhakian; Walter G Wasser; Benjamin D Fox; Baruch Vainshelboim; Mordechai R Kramer
Journal:  Dis Markers       Date:  2016-04-18       Impact factor: 3.434

10.  Role of the Neutrophil-Lymphocyte Ratio in the Differential Diagnosis of Exudative Pleural Effusion.

Authors:  Ulku Aka Akturk; Dilek Ernam; Makbule Ozlem Akbay; Nagihan Durmus Koçak; Erhan Ogur; Ilim Irmak
Journal:  Clinics (Sao Paulo)       Date:  2016-10-01       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.